Press releases

Month Year

Email alerts

Mar 29, 2014

Medtronic Releases Results of SYMPLICITY HTN-3

Medtronic Commits to Further Clinical Investigation and Determining Path Forward for Next U.S. IDE with FDA

MINNEAPOLIS and WASHINGTON, DC - March 29, 2014 - Medtronic, Inc. (NYSE: MDT) today announced the full results of the SYMPLICITY HTN-3 clinical trial, which were presented today in late-breaking...
Mar 28, 2014

AORN Foundation, Covidien Team to Offer New Tools for Emerging Nurse Leaders

DENVER, Colo. and DUBLIN, Ireland – March 28, 2014 – In a move aimed at giving nursing professionals the tools they need to address rapidly changing practices and cost structures, the AORN...
Mar 27, 2014

First Patients Enrolled in Medtronic Clinical Study Designed to Identify Patients at High Risk for Sudden Cardiac Arrest in Developing Countries

Study Will Assess Defibrillator Therapy in Patients Most At-Risk for SCA

Minneapolis - March 27, 2014 -Medtronic, Inc. (NYSE:MDT) today announced the first patients were enrolled in the Improve SCA Clinical Study, a first-of-its-kind study that will identify patients...
Mar 25, 2014

Study Published in JAMA Shows Covidien Endoscopic Ablation Therapy Effective In Treating Barrett’s Esophagus

DUBLIN--(BUSINESS WIRE)--Mar. 25, 2014-- An innovative Covidien (NYSE: COV) technology is effective at treating Barrett’s esophagus (a precancerous condition of the esophagus), according to a...
Mar 19, 2014

Covidien Declares Quarterly Cash Dividend

DUBLIN, Ireland--(BUSINESS WIRE)--Mar. 19, 2014-- Covidien plc (NYSE:COV) today announced that its Board of Directors has declared a quarterly cash dividend of $0.32 per ordinary share. The...

Show per page

Su	Mo	Tu	We	Th	Fr	Sa

Su	Mo	Tu	We	Th	Fr	Sa